Ascendis Pharma A/S

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
Employees
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
Employees

ASND Key Statistics

Market cap
16.18B
Market cap16.18B
Price-Earnings ratio
18.42
Price-Earnings ratio18.42
Dividend yield
Dividend yield
Average volume
582.48K
Average volume582.48K
High today
High today
Low today
Low today
Open price
$250.14
Open price$250.14
Volume
0.00
Volume0.00
52 Week high
$282.15
52 Week high$282.15
52 Week low
$186.05
52 Week low$186.05

Stock Snapshot

Ascendis Pharma A/S(ASND) stock is priced at $246.51, giving the company a market capitalization of 16.18B. It carries a P/E multiple of 18.42.

On 2026-08-14, Ascendis Pharma A/S(ASND) shares started trading at $250.14, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 582.48K.

Over the past 52 weeks, Ascendis Pharma A/S(ASND) stock has traded between a high of $282.15 and a low of $186.05.

Over the past 52 weeks, Ascendis Pharma A/S(ASND) stock has traded between a high of $282.15 and a low of $186.05.

ASND News

Investing.com 22h
Earnings call transcript: Ascendis Pharma tops Q2 2026 estimates as launches gain - Investing.com

...

Earnings call transcript: Ascendis Pharma tops Q2 2026 estimates as launches gain - Investing.com
TipRanks 22h
Ascendis Pharma Doubles Q2 Revenue as Rare Disease Portfolio Scales and Debt Retired

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

100%

of 20 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ASND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.